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Voluntary and regulatory restrictions since the 1970s on the use of lead in gasoline, paint, and soldered food cans 
resulted in a progressive decline in the exposure of populations 
to lead. In the United States, the National Health and Nutrition 
Examination Survey (NHANES) documented a progressive 
decline in the geometric blood lead concentration over time. 
Among adults, mean blood lead levels decreased from 13.1 μg/dL 
in NHANES II (1976–1980)1,2 to 2.76 μg/dL in NHANES 
III (1988–1994)3 and next to 1.64 μg/dL in NHANES IV 
(1999–2002).3
High-level lead exposure causes hypertension.4,5 In a previ-
ous meta-analysis, we reported that a 2-fold increase in the 
blood lead concentration was associated with a higher blood 
pressure with estimated effect sizes of 1.0 mm Hg (95% con-
fidence interval [CI], 0.5–1.4 mm Hg) systolic and 0.6 mm Hg 
(0.4–0.8 mm Hg) diastolic.4 In our analysis of NHANES III 
data,6 the median blood lead concentrations among blacks 
and whites of either sex ranged from 2.1 to 4.2 μg/dL. The 
multivariable-adjusted changes in blood pressure associated 
with a doubling of blood lead were inconsistent across the 4 
ethnicity-sex strata and ranged from +0.1 mm Hg (P=0.80) 
to +1.2 mm Hg (P=0.004) systolic and from −0.6 mm Hg 
(P=0.0003) to +0.5 mm Hg (P=0.047) diastolic.6 In view of 
the continuing declining environmental lead exposure in the 
United States,1,3 and the apparent ethnic diversity in NHANES 
III in the associations of blood pressure with blood lead,6,7 we 
aimed at reanalyzing the relationship between blood pressure 
and blood lead in NHANES IV (2003–2010).
Methods
Field Work
The US National Center for Health Statistics (Centers for Disease 
Control and Prevention, Atlanta, GA) conducted NHANES IV 
(1999–2012). Interviews were conducted at the participants’ homes. 
The comprehensive physical examinations, which included measure-
ments of anthropometric characteristics, blood pressure, and collec-
tion of blood and urine samples, took place at mobile examination 
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centers. The National Center for Health Statistics Institutional 
Review Board approved the interviews, physical examinations, and 
the procedure to obtain written informed consent. The details of the 
field work are described in the Expanded Methods in the online-only 
Data Supplement (page S2).
Selection of Participants
The NHANES IV data considered for the current analysis were col-
lected in 7 stages: 1999 to 2000, 2001 to 2002, 2003 to 2004, 2005 to 
2006, 2007 to 2008, 2009 to 2010, and 2011 to 2012. The pooled data 
initially comprised 71 916 people examined from 1999 until 2012. In 
keeping with our previous report,6 we planned to account for dietary 
habits. This forced us to excluded participants examined from 1999 to 
2002, because the protocol for collecting dietary information substan-
tially changed in 2002 and people examined in 2011 and 2012, because 
dietary information was lacking in the online database (accessed 
February 20, 2014). After exclusion of participants with missing or 
unreliable data, the number of analyzed participants totaled 12 725. The 
Expanded Methods in the online-only Data Supplement (pages S2–S3) 
provide detailed information on selection and exclusion criteria and 
on the representativeness of the participants retained in the analysis. 
Self-reported ethnicity was categorized as non-Hispanic white, non-
Hispanic black, and Hispanic.
Measurements
At mobile examination centers, trained observers measured anthro-
pometric characteristics and blood pressure. Blood pressure was 
the average of ≤3 readings. The number of blood pressure readings 
available for analysis was 3 in 11 601 participants (91.2%), 2 in 626 
(4.9%), and only 1 in 498 (3.9%). Hypertension was a blood pressure 
of ≥140 mm Hg systolic or 90 mm Hg diastolic or the use of antihy-
pertensive drugs. Pulse pressure was the difference of systolic minus 
diastolic blood pressure. Mean arterial pressure was diastolic blood 
pressure plus one third of pulse pressure. The Expanded Methods in 
the online-only Data Supplement (pages S3–S5) provide a thorough 
description of the methods used for administering questionnaires, 
recording dietary habits, and the methods used for the biochemical 
measurements including blood lead.
Statistical Analysis
For database management and statistical analysis, we used SAS 
software, version 9.3 (SAS Institute Inc, Cary, NC). For vari-
ables that required a logarithmic transformation to approximate 
a normal distribution, including blood lead, serum cotinine, and 
γ-glutamyltransferase, and dietary calcium and caffeine, we reported 
the central tendency and spread of the data as the geometric mean and 
the interquartile range. Between-group comparisons of means relied 
on the standard normal z test or Tukey test for multiple comparisons. 
For between-group comparisons of proportions, we applied the χ2 
statistic test with Bonferroni correction of the significance levels if 
multiple groups were involved.
Details of the analysis plan and the statistical tests applied appear 
in the Expanded Methods in the online-only Data Supplement (pages 
S5–S6). In a first step of the analysis, we plotted mean values of sys-
tolic and diastolic blood pressure by deciles of the blood lead con-
centration for each of the 6 ethnicity-sex strata separately. Next, we 
searched for covariables significantly and independently associated 
with blood pressure in a stepwise regression procedure with P values 
for explanatory variables to enter and stay in the model set at 0.15. 
After having determined the standard set of covariables to adjust for, 
we computed for each ethnicity-sex stratum the multivariable-adjust-
ed associations between blood pressure and blood lead. We tested 
between-group differences in these association by introducing the ap-
propriate interaction terms with blood lead in the models.
Results
Characteristics of Participants by Ethnicity and Sex
The 12 725 participants included 2692 (21.1%) blacks, 2607 
(20.5%) Hispanics, 7426 (58.4%) whites, and 6199 (48.7%) 
women. The characteristics listed in Table 1 are significantly 
different between the 3 ethnic groups (P<0.0001) except for 
pulse pressure (P=0.66) and heart rate (P=0.30). The online-
only Data Supplement includes a detailed description of the 
differences in the characteristics of participants by ethnicity 
(page S6) and sex (page S7). The blood lead concentration 
was lower (P<0.0001) among whites when compared with 
black and Hispanic participants (1.46 versus 1.57 μg/dL) 
with no difference (P=0.12) between Hispanics (1.55 μg/dL) 
and blacks (1.60 μg/dL). Women had a lower blood lead 
concentration than men had (1.25 versus 1.80 μg/dL; 
P<0.0001). When adjusted for hematocrit, the blood lead 
concentration remained lower in women than in men (1.29 
versus 1.74 μg/dL; P<0.0001). Figure S1 in the online-only 
Data Supplement describes the distributions of blood lead by 
ethnicity and sex.
Unadjusted Analyses
The Figure shows that in the unadjusted analysis of the 
6 ethnicity-sex strata, systolic blood pressure increased 
(P<0.0001) with higher blood lead concentration and that 
a linear model was adequate to describe the data. The cor-
responding associations with diastolic blood pressure were 
significantly positive (P≤0.018) or not significant (P≥0.33) 
but also suggested that a linear model accurately captured the 
data (Figure S2).
In unadjusted analyses of all participants, systolic and dia-
stolic pressure increased (P<0.0001) with higher blood lead 
(Table S1). The effect sizes associated with a doubling of the 
blood lead concentration were 4.80 mm Hg (95% CI, 4.46–
5.14) for systolic pressure and 0.67 mm Hg (CI, 0.45–0.89) 
for diastolic pressure (Table S1). Considering the six ethnic-
ity-sex strata, systolic and diastolic pressure also increased 
with higher blood lead (P≤0.018), except for diastolic pres-
sure (Table S1) in white women (P=0.69) and non-Black men 
(P≥0.33). In unadjusted analyses, pulse pressure and mean 
arterial blood pressure consistently increased (P≤0.0095) with 
blood lead in all ethnicity-sex strata and in all participants 
(Table S2, page S7).
Among all participants, 4893 (38.5%) had hypertension. 
The diagnosis of hypertension rested on a systolic pressure 
of ≥140 mm Hg in 1903 subjects, a diastolic pressure of ≥90 
mm Hg in 228, an elevation of both systolic and diastolic 
pressure in 406, and the use of antihypertensive drugs in 
2356 participants, in whom the aforementioned blood pres-
sure criteria were not met. The unadjusted odds ratio for 
a doubling of the blood lead concentration (Table S3) was 
1.58 (95% CI, 1.52–1.65) in all participants. Across the 6 
ethnicity-sex strata, except for Hispanic men (P=0.12), the 
unadjusted odd ratios were significant (P<0.0001), rang-
ing from 1.51 in Hispanic women to 2.17 in white women 
(Table S3).
Identification of Covariables
Covariables of systolic and diastolic pressure, as selected 
by stepwise regression, appear in Table 2. Age was the most 
important independent covariable, explaining 20.5% and 
11.4% of the systolic and diastolic variance, respectively 
(Table 2). With whites as reference, both blacks and Hispanics 
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had higher systolic pressure (Table 2). Blacks also had higher 
diastolic pressure (Table 2). Systolic pressure was inversely 
associated with heart rate, whereas the opposite was the case 
for diastolic pressure. Both systolic and diastolic pressure sig-
nificantly (P≤0.0035) and independently increased with body 
mass index, γ-glutamyltransferase as index of alcohol intake, 
hematocrit and the dietary sodium:potassium ratio. Users of 
antihypertensive drugs had higher blood pressure. Diastolic 
pressure was independently and inversely correlated with 
serum cotinine. College graduation was associated with lower 
systolic and diastolic pressure. Taken together, all covariables 
selected explained 25.7% of systolic pressure and 17.9% of 
diastolic pressure.
The online-only Data Supplement (Table S4, page S8) 
shows that the covariables associated in stepwise regression 
with pulse pressure and mean arterial pressure were simi-
lar as those correlated with systolic and diastolic pressure 
and together explained 35.6% of pulse pressure and 14.8% 
of mean arterial pressure. On the basis of above results, we 
adjusted all regression models relating blood pressure compo-
nents to blood lead for ethnicity and sex (as appropriate), the 
linear and squared terms of age, body mass index, heart rate, 
hematocrit, serum total calcium, γ-glutamyltransferase and 
cotinine, the dietary sodium:potassium intake ratio, attain-
ment of a college grade, and antihypertensive drug treatment.
Multivariable-Adjusted Association of Blood 
Pressure With Blood Lead
Among women, the multivariable-adjusted associations 
between systolic and diastolic pressure and blood lead 
Table 1. Characteristics of Participants
Characteristic
Women Men
Black Hispanic White Black Hispanic White
No. in category 1346 1233 3620 1346 1374 3806
No. with characteristics (%)
  Current smoker 276 (20.5) 139 (11.3) 800 (22.1) 394 (29.3) 341 (24.8) 918 (24.1)
  Drinking alcohol 69 (5.1) 33 (2.7) 255 (7.0) 228 (16.9) 311 (22.6) 812 (21.3)
  Diabetes mellitus 230 (17.1) 222 (18.0) 367 (10.1) 222 (16.5) 218 (15.9) 485 (12.7)
  On antidiabetic drugs 192 (14.3) 174 (14.1) 268 (7.4) 174 (12.9) 162 (11.8) 345 (9.1)
  Hypertension 629 (46.7) 416 (33.7) 1383 (38.2) 573 (42.6) 382 (27.8) 1510 (39.7)
  On antihypertensive drugs 518 (38.5) 294 (23.8) 1068 (29.5) 402 (29.9) 240 (17.5) 1123 (29.5)
  Poverty index below threshold 303 (22.5) 387 (31.4) 506 (14.0) 237 (17.6) 405 (29.5) 424 (11.1)
  High-school education 991 (73.6) 579 (47.0) 3030 (83.7) 963 (71.6) 597 (43.5) 3144 (82.6)
  College graduate 231 (17.2) 101 (8.2) 903 (24.9) 201 (14.9) 99 (7.2) 1046 (27.5)
Mean of characteristic (±SD)
  Age, y 48.3±16.8 48.1±16.8 53.0±18.4 47.7±16.9 46.1±16.8 53.1±18.6
  Body mass index, kg/m2 31.5±7.8 29.8±6.1 28.1±6.9 28.8±6.5 28.6±5.0 28.5±5.8
  Systolic pressure, mm Hg 125.6±20.7 123.0±20.9 122.6±20.4 127.5±17.3 124.5±17.2 125.2±16.7
  Diastolic pressure, mm Hg 70.7±12.2 68.6±10.8 68.4±11.4 73.1±12.8 70.4±11.5 70.8±11.8
  Mean arterial pressure, mm Hg 89.0±12.6 86.7±11.8 86.5±11.4 91.2±12.2 88.4±11.2 89.0±11.0
  Pulse pressure, mm Hg 54.9±19.2 54.4±19.3 54.2±20.7 54.4±16.3 54.1±16.6 54.4±17.1
  Heart rate, bpm 74.1±12.2 73.4±11.0 74.0±11.9 70.2±12.9 70.2±11.8 70.4±12.4
  Hematocrit, % 38.2±3.7 39.4±3.5 40.2±3.3 43.3±3.7 45.1±3.4 44.5±3.7
  Total cholesterol, mg/dL 194.3±40.6 199.3±40.4 203.1±42.0 192.4±41.8 200.8±41.7 193.1±41.0
  Serum creatinine, mg/dL 0.83±0.20 0.69±0.16 0.81±0.19 1.07±0.20 0.90±0.18 1.01±0.19
  Serum glucose, mg/dL 100.0±38.9 105.8±45.2 96.4±27.0 101.7±38.7 108.9±48.4 101.2±32.3
  Serum protein, g/dL 7.30±0.49 7.28±0.43 7.01±0.42 7.37±0.51 7.36±0.46 7.10±0.44
  Serum total calcium, mg/dL 9.49±0.39 9.38±0.37 9.47±0.37 9.55±0.38 9.45±0.34 9.49±0.35
  Dietary sodium:potassium ratio 1.51±0.63 1.28±0.57 1.31±0.59 1.54±0.66 1.30±0.56 1.37±0.58
Geometric mean (IQR)
  Blood lead, μg/dL 1.37 (0.88–2.10) 1.21 (0.80–1.78) 1.22 (0.80–1.86) 1.86 (1.20–2.85) 1.94 (1.25–2.83) 1.73 (1.16–2.57)
  Cotinine, ng/mL 0.57 (0.03–22.4) 0.07 (0.01–0.10) 0.27 (0.01–1.66) 1.77 (0.05–160) 0.27 (0.02–3.46) 0.74 (0.02–139)
  γ-glutamyltransferase, units/L 21.7 (15.0–28.0) 20.0 (13.0–28.0) 18.2 (12.0–24.0) 28.6 (19.0–39.0) 29.4 (19.0–40.0) 24.5 (16.0–34.0)
  Dietary calcium, g/d 0.55 (0.38–0.87) 0.68 (0.46–1.03) 0.72 (0.50–1.08) 0.67 (0.44–1.08) 0.80 (0.55–1.23) 0.90 (0.62–1.34)
  Dietary caffeine, mg/d 18.6 (1.00–112) 32.6 (5.00–147) 74.2 (43.0–275) 23.4 (1.00–142) 48.7 (29.0–192) 101 (64.0–332)
Hypertension was a blood pressure of ≥140 mm Hg systolic or ≥90 mm Hg diastolic or the use of antihypertensive drugs. Diabetes mellitus was a fasting or 
random blood glucose of ≥126 mg/dL or ≥200 mg/dL, respectively, the use of antidiabetic drugs, or a self-reported diagnosis. IQR indicates interquartile range
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(Table 3) did not reach significance in any of the ethnic 
groups (P≥0.090), except for diastolic pressure in white 
women, which was +0.73 mm Hg higher (95% CI, +0.23 to 
+1.24; P=0.0045) for a 2-fold increase in blood lead. In all 
women combined, the effect sizes associated with a dou-
bling of the blood lead concentration were +0.58 mm Hg 
(95% CI, +0.01 to +1.17; P=0.050) for systolic pressure 
and +0.43 (95% CI, 0.07 to +0.80; P=0.021) for diastolic 
pressure. Among men, systolic pressure was significantly 
and independently associated with the blood lead concen-
tration in black and Hispanic men (P≤0.038), whereas the 
corresponding association in white men was statistically 
weaker (P=0.060). The effect sizes for a doubling of the 
blood lead concentration ranged from +1.61 mm Hg in 
blacks to +0.65 mm Hg in whites. In all men combined, 
the effect size was +0.79 mm Hg (95% CI, +0.30 to +1.27; 
P=0.0015). The relationship between diastolic pressure 
and blood lead did not reach formal significance (P≥0.062) 
among black and Hispanic men. In white men, diastolic 
pressure was significantly and positively associated with 
blood lead (effect size, +0.70 mm Hg; 95% CI, +0.24 to 
+1.17; P=0.0032). Among all participants, for each 2-fold 
increase in the blood lead concentration, blood pressure 
components increased, by +0.76 mm Hg (95% CI, +0.38 
to +1.13; P<0.0001) for systolic pressure and by +0.43 
mm Hg (95% CI, +0.18 to +0.68; P=0.0007) for diastolic 
pressure (Table 3).
For systolic blood pressure, all interaction terms of eth-
nicity and sex with blood lead were significant (P≤0.019). 
For diastolic pressure, the interaction terms of ethnicity 
and sex with lead were nonsignificant (P≥0.17), except 
for the interaction between Hispanic ethnicity and blood 
lead in relation to diastolic blood pressure. This interac-
tion indicated that for a doubling of blood lead the increase 
in diastolic pressure among Hispanics was 0.70 mm Hg 
less (−1.20 to −0.20 mm Hg; P=0.0057) than in the other 
ethnicities.
The online-only Data Supplement gives full information on 
the multivariable-adjusted associations of pulse pressure and 
mean arterial pressure with blood lead in all participants and 
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Figure. Unadjusted associations 
between systolic blood pressure 
and blood lead by ethnicity-sex 
strata. The regression line with 95% 
confidence interval was computed 
using the individual subjects in each 
stratum. The dots plotted over the 
regression line represent the means 
of systolic blood pressure and lead 
in each decile of the ethnicity- and 
sex-specific distributions. Vertical 
bars denote the SE of systolic blood 
pressure. The Figure confirmed 
the adequacy of the linear model 
in addition to the statistical tests 
described in the Methods section of 
this article.
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in the 6 ethnicity-sex strata (Table S5, pages S8–S9). Among 
all participants, mean arterial pressure was 0.54 mm Hg higher 
(95% CI, 0.29–0.79; P<0.0001) for each 2-fold increase in 
the blood lead concentration, whereas there was no significant 
association between pulse pressure and blood lead even when 
all participants were pooled (Table S5). For pulse pressure, 
interactions of ethnicity and sex with blood lead were all sig-
nificant (P≤0.027). For mean arterial pressure, all interaction 
terms of ethnicity and sex with blood lead were nonsignificant 
(P≥0.096).
Multivariable-Adjusted Risk of Hypertension in 
Relation to Blood Lead
The odds of having hypertension associated with a doubling 
of the blood lead concentration (Table 4) only reached for-
mal significance in black women (P=0.049) and Hispanic 
men (P=0.042), in whom the odds ratios were 0.82 (95% 
CI, 0.67–0.99) and 0.84 (CI, 0.71–0.99), respectively. For all 
other subgroups, the odds ratios were not statistically signifi-
cant (P≥0.12). Among all participants, the odds ratio was 0.95 
(95% CI, 0.90–1.01; P=0.11).
Table 2. Correlates of Blood Pressure Components
Covariables
Systolic Blood Pressure, mm Hg Diastolic Blood Pressure, mm Hg
Effect Size (95% CI) r 2 (%) P Value Effect Size (95% CI) r 2 (%) P Value
Black vs white (1,0) 3.98 (3.22 to 4.74) 0.81 <0.0001 2.20 (1.71 to 2.70) 0.87 <0.0001
Hispanic vs white (1, 0) 2.14 (1.38 to 2.89) <0.0001 –1.27 (–1.78 to –0.77) <0.0001
Age (+18.0 y) –0.27 (–2.05 to 1.50) 20.5 0.76 21.4 (20.3 to 22.6) 11.4 <0.0001
Age2 (+1875 y2) 8.18 (6.41 to 9.95) <0.0001  –22.4 (–23.5 to –21.2) <0.0001
Body mass index (+6.5 kg/m2) 1.28 (0.98 to 1.59) 0.37 <0.0001 0.43 (0.23 to 0.63) 0.17 <0.0001
Heart rate (+12.2 bpm) –0.53 (–0.82 to –0.24) 0.07 0.0004 1.31 (1.12 to 1.50) 1.35 <0.0001
γ-glutamyltransferase (×2) 1.78 (1.45 to 2.11) 1.77 <0.0001 0.59 (0.37 to 0.80) 0.26 <0.0001
Cotinine (×2) … … … –0.18 (–0.21 to –0.14) 0.53 <0.0001
Hematocrit (+4.3%) 1.14 (0.84 to 1.44) 0.44 <0.0001 2.42 (2.22 to 2.62) 3.23 <0.0001
College graduate (1, 0) –2.59 (–3.32 to –1.86) 0.28 <0.0001 –0.50 (–0.99 to –0.01) 0.03 0.047
Antihypertensive drugs (1, 0) 4.32 (3.59 to 5.05) 1.26 <0.0001 0.48 (–0.01 to 0.96) 0.02 0.051
Dietary sodium:potassium ratio (+0.60) 0.45 (0.16 to 0.75) 0.05 0.0027 0.29 (0.10 to 0.48) 0.06 0.0035
Serum total calcium (+0.37 mg/dL) 0.73 (0.44 to 1.03) 0.12 <0.0001 … … …
Total explained variance (R2) ... 25.7 ... ... 17.9 ...
Effect sizes (95% CI) express the multivariable-adjusted change in blood pressure associated with the explanatory variables, as category, on 
a linear scale (+1-SD), or on a logarithmic scale (doubling). The explanatory variables were selected by a stepwise regression procedure with 
the P values for variables to enter and stay in the models set at 0.15. The linear and squared terms of age, as well as the design variables coding 
for ethnicity, were offered together for entry into the model. An ellipsis indicates that a variable did not enter the model. Variables considered 
that did not enter in any model were sex, dietary intake of calcium and caffeine, and the poverty index ratio. R2 and r2 indicate the variance 
explained in percentage by the whole model or by single or sets of variables. CI indicates confidence interval.
Table 3. Multivariable-Adjusted Association of Blood Pressure Components with Blood Lead
Strata by Ethnicity and Sex
Systolic Blood Pressure, mm Hg Diastolic Blood Pressure, mm Hg
Effect Size (95% CI) r 2, % P Value Effect Size (95% CI) r 2, % P Value
Women
  Black (n=1346) 1.18 (–0.19 to 2.55) 0.16 0.090 0.52 (–0.34 to 1.37) 0.09 0.24
  Hispanic (n=1233) 0.56 (–0.57 to 1.69) 0.05 0.33 –0.13 (–0.81 to 0.55) >0.00 0.71
  White (n=3620) 0.61 (–0.18 to 1.40) 0.04 0.13 0.73 (0.23 to 1.24) 0.19 0.0045
  All women (n=6199) 0.58 (0.01 to 1.17) 0.04 0.050 0.43 (0.07 to 0.80) 0.07 0.021
Men
  Black (n=1346) 1.61 (0.45 to 2.76) 0.46 0.0066 0.81 (–0.04 to 1.66) 0.21 0.062
  Hispanic (n=1374) 0.95 (0.05 to 1.84) 0.24 0.038 –0.03 (–0.64 to 0.58) >0.00 0.92
  White (n=3806) 0.65 (–0.03 to 1.32) 0.08 0.060 0.70 (0.24 to 1.17) 0.18 0.0032
  All men (n=6526) 0.79 (0.30 to 1.27) 0.13 0.0015 0.47 (0.13 to 0.81) 0.09 0.0072
All participants (n=12 725) 0.76 (0.38 to 1.13) 0.09 <0.0001 0.43 (0.18 to 0.68) 0.07 0.0007
Effect sizes (95% CI) express the multivariable-adjusted change in blood pressure associated with a doubling of the blood lead concentration. 
Estimates were adjusted for ethnicity and sex (as appropriate), the linear and squared terms of age, body mass index, heart rate, hematocrit, 
serum total calcium, γ-glutamyltransferase and cotinine, the dietary sodium:potassium intake ratio, college education, and antihypertensive 
drug treatment. CI indicates confidence interval.
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Sensitivity Analyses
The sensitivity analyses (Tables S6–S8, pages S9–S10) con-
firmed the primary findings.
Discussion
We undertook our current study in view of the steadily 
declining blood lead levels in the United States. The blood 
lead concentration averaged 13.1 μg/dL1 in NHANES II 
(1976–1980), declined to 2.76 μg/dL in NHANES III (1988–
1994),3 and to 1.64 μg/dL and 1.41 μg/dL in NHANES IV 
(1999–20023 and 2005–20068). In our present study (2003–
2010), the mean blood lead concentration was 1.51 μg/dL. 
The key findings can be summarized in 4 points. First, across 
6 ethnicity-sex strata, the relationship between the blood 
pressure components was inconsistent, usually with larger 
effects sizes among men than women and among blacks than 
non-blacks. Second, the effect sizes, although significant 
for systolic, diastolic, and mean arterial pressure in pooled 
analyses of all women and men combined, were all smaller 
than 0.79 mm Hg. Third, pulse pressure was not related to 
blood lead, except for a weak association in Hispanic men. 
Fourth, the small effect sizes explain why overall the odds of 
having hypertension was not associated with the blood lead 
concentration.
A comprehensive review of previous studies of the asso-
ciation of blood pressure or the prevalence of hypertension 
with lead exposure3,4,8 is beyond the scope of this article 
but is available in the online-only Data Supplement (pages 
S10–S12). The current literature shows discrepancy between 
studies in populations and workers. The explanations that 
are commonly put forward for this apparent discrepancy are 
the higher statistical power in large epidemiological surveys 
relative to smaller occupational cohorts and selection bias, 
often referred to as the healthy worker effect. Considering 
the available literature, NHANES is undoubtedly the most 
appropriate data source to address the issue of the potential 
association of blood pressure or hypertension with environ-
mental lead exposure. NHANES conducted by the National 
Center for Health Statistics is the principal resource for track-
ing progress in reducing lead in the environment. Because 
NHANES surveyed a large probability sample of the general 
population, the findings can be generalized to the United 
States as a whole. Moreover, individuals with high exposure 
or at risk of high exposure were excluded from the NHANES 
sample. Previous NHANES phases showed a substantial 
decline in blood lead levels.1,3,8 The percentage of adults with 
blood lead level of 10 μg/dL or higher was as low as 0.7% in 
1999 to 2002.3
Two previous NHANES IV studies reported on the 
association of blood pressure or the risk of hypertension 
with blood lead.3,8 Both studies confirmed that blood lead 
levels continue to decline among adults in United States, 
but that racial and ethnic disparities persist.3,8 One study 
reported that blood lead levels were significantly associated 
with higher systolic blood pressure among black men and 
women, but not among white or Mexican-American par-
ticipants, and that blood lead was significantly correlated 
with higher diastolic blood pressure among white men and 
women and black men, whereas a negative association was 
observed in Mexican-American men.8 The second study 
reported that blood lead levels remained associated with 
a higher burden of chronic kidney disease and peripheral 
arterial disease.3 Our current analysis essentially showed 
that the low levels of lead that exist today in the United 
States have little influence on blood pressure. Our analytic 
approach also differed from the 2 previously published 
reports in several aspects. First, in unadjusted analyses, we 
tested the adequacy of the linear model to describe the rela-
tionship between blood pressure and blood lead. Second, 
in our multivariable-adjusted analyses, we analyzed blood 
lead as a continuous variable instead of examining the 
linear trend across quartiles3 or contrasting the bottom 
with the top decile.8 Third, we analyzed both the pulsatile 
components (systolic pressure and pulse pressure) and the 
steady components (diastolic pressure and mean arterial 
pressure) of blood pressure. Our observation that pulse 
pressure was unrelated to blood lead is at variance with 
studies relating peripheral arterial disease or cardiovascu-
lar disease with lead exposure.9,10 However, smoking was a 
major confounder in these reports.9,10 Fourth, we adjusted 
for a large number of covariables, including aspects of life-
style that previous NHANES studies3,8 did not consider, 
such as nutritional factors, social status, and serum cotinine 
and γ-glutamyltransferase, as biomarkers of smoking and 
drinking alcohol.
Our current study must be interpreted within the context 
of its limitations. First, the cross-sectional nature of our 
current analysis does not allow to make any causal inter-
ferences about the association between blood pressure and 
the prevalence of hypertension in relation to lead exposure. 
Second, we cannot ascertain that we accounted for all con-
founders, in particular, when we assessed the association 
between blood pressure and blood lead across 6 ethnic-
ity-sex strata. Third, blood pressure was the average of 3 
Table 4. Adjusted Association Between Hypertension and 
Blood Lead
Strata by Ethnicity and Sex Odds Ratio (95% CI) P Value
Women
  Black (n=1346) 0.82 (0.67–0.99) 0.049
  Hispanic (n=1233) 0.86 (0.72–1.04) 0.12
  White (n=3620) 1.06 (0.94–1.21) 0.33
  All women (n=6199) 0.95 (0.87–1.04) 0.26
Men
  Black (n=1346) 1.00 (0.84–1.20) 0.97
  Hispanic (n=1374) 0.84 (0.71–0.99) 0.042
  White (n=3806) 0.99 (0.89–1.10) 0.78
  All men (n=6526) 0.95 (0.87–1.02) 0.17
All participants (n=12 725) 0.95 (0.90–1.01) 0.11
Effect sizes (95% CI) express the multivariable-adjusted risk of having 
hypertension associated with a doubling of the blood lead concentration. 
Odds ratios were adjusted for ethnicity and sex (as appropriate), the linear and 
squared terms of age, body mass index, heart rate, hematocrit, serum total 
calcium, γ-glutamyltransferase and cotinine, college education, and the dietary 
sodium:potassium intake ratio. CI indicates confidence interval
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conventional blood pressure readings. Out-of-the-office 
blood pressure measurement by ambulatory monitoring or 
self-measurement at home is the current state of the art to 
assess blood pressure.11 Fourth, a potential limitation of our 
study was that we did not measure bone lead as exposure 
marker. Approximately 95% of the total body burden of lead 
is present in the skeleton, and measurement of bone lead 
levels can provide a more reliable measure of the internal 
dose.12 Some investigators reported that hypertension was 
associated with bone lead, but not with blood lead.13,14 A 
possible drawback of using bone lead as exposure index is 
that bone levels increase with age, as blood pressure does, 
making it difficult to correct for age effects. Furthermore, 
the upper end of bone lead levels reported in previous 
studies13,14 was characteristic of occupational rather than 
environmental exposure. Blood lead reflects both recent 
exogenous exposure and endogenous redistribution of the 
lead stored in bone, but may underestimate the internal dose 
of lead.
Perspectives
In our current study, the increase from the low to high end 
of the distribution was ≈10-fold. The 5th to 95th percentile 
interval encompassed 0.54 and 4.35 μg/dL. In the unlikely 
event that a patient would move from the bottom to the top of 
the blood lead distribution, which would translate in a maxi-
mum increase in blood pressure by ≈5 mm Hg systolic or ≈3 
mm Hg diastolic. Furthermore, in our current cross-sectional 
analysis, there was no consistent relationship of the blood 
pressure level or the prevalence of hypertension with the 
blood lead concentration. The association between hyper-
tension and blood lead was not significant. Accordingly, 
lead exposure within the range studied might not entail any 
excess morbidity or mortality attributable to hypertension 
and its cardiovascular complications.15 However, more pro-
spective population studies with assessment of both fatal and 
nonfatal cardiovascular end points are required to confirm 
this assertion. The currently available prospective popula-
tion studies15–19 are contradictory, reporting positive16–19 or 
null15 associations between outcome and lead exposure, but 
to our knowledge only 215,16 accounted for both fatal and 
nonfatal events. Not having the nonfatal outcomes in an era 
when invasive cardiologist remove obstructions and restore 
patency of coronary arteries, when coronary bypass surgery 
became a low-risk procedure, and when stroke units are 
delivering specialized intensive care, recording the nonfatal 
events should become the state of the art. Finally, for now, 
no study captured the low end of the exposure–response rela-
tionship for blood lead levels and end points of cardiovascu-
lar function in lead workers. Therefore, studies specifically 
addressing these issues in a longitudinal follow-up of lead 
exposed workers who will go from no previous occupational 
(general population blood lead levels) to occupational lead 
exposures are needed.
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What Is New?
•	 In the United States, the National Health and Nutrition Examination Sur-
vey documented a progressive decline in blood lead. National Health 
and Nutrition Examination Survey III (1988–1994) documented ethnic 
diversity in the association of blood pressure with blood lead. Therefore, 
we analyzed 12 725 people included in the National Health and Nutrition 
Examination Survey IV (2003–2010) database.
What Is Relevant?
•	The association between blood pressure components and blood lead was 
inconsistent across 6 strata based on ethnicity (blacks, Hispanics, and 
whites) and sex.
•	Among 6199 women, the adjusted effect sizes associated with a dou-
bling of blood lead were +0.58 mm Hg (P=0.05) systolic and +0.43 
(P=0.021) diastolic.
•	Among 6526 men, the corresponding effect sizes were +0.79 mm Hg 
(P=0.0015) and +0.47 (P=0.0072), respectively.
•	Among all participants, the odds ratio for hypertension associated with a 
doubling of blood lead was 0.95 (P=0.11).
Summary
At the currently declining exposure levels, associations of blood 
pressure with blood lead were inconsistent across the ethnicity-
sex strata. The effect sizes, although significant in pooled analyses 
of all women and men, were smaller than 0.79 mm Hg and likely 
exclude current environmental lead exposure in the United States 
as a clinically meaningful cause of hypertension.
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Expanded Methods  
Field Work   
The United States (US) National Center for Health Statistics (NCHS: Centers for Disease 
Control and Prevention, Atlanta, GA) conducted NHANES IV (1999–2012).  NHANES con-
sists of cross-sectional, nationally representative surveys of the non-institutionalized civilian 
population of the US.  The survey employs a multistage stratified probability sample based 
on selected counties, blocks, households, and persons within households.  Certain sub-
groups of the population, such as Mexican Americans, black non-Hispanics, and older adults 
were oversampled to improve the precision of estimates for these groups.  Interviews were 
conducted at the participants’ homes.  The comprehensive physical examinations, which in-
cluded measurements of anthropometric characteristics, blood pressure and collection of 
blood and urine samples took place at mobile exam centers (MEC).  The NCHS Institutional 
Review Board approved the interviews, physical examinations, and the procedure to obtain 
written informed consent.    
Selection of Participants   
The NHANES IV data considered for the current analysis were collected in seven stages, 
1999–2000, 2001–2002, 2003–2004, 2005–2006, 2007–2008, 2009–2010, and 2011–2012.  
From the NHANES IV database available online, we downloaded and pooled 80 datasets 
containing information on anthropometric characteristics, biochemical measurements, life-
style, dietary habits, socio-economic status, and the blood lead concentration.  The pooled 
data initially comprised 71,916 people examined from 1999 until 2012.  Of those, we exclud-
ed 3211, because they did not undergo the physical examination.  We furthermore removed 
from analysis 32,634 participants younger than 20 years, 4766 whose ethnicity was unde-
termined, and 1324 women who were either pregnant (n=1114) or breast-feeding (n=210).   
In keeping with our previous report,1 we planned to account for dietary habits.  This forced 
us to exclude 8111 participants examined from 1999 until 2002, because the protocol for col-
lecting dietary information substantially changed in 2002 and a further 3814 people exam-
ined in 2011 and 2012, because dietary information was lacking in the online database.  We 
had to disregard an additional 5193 participants because of missing covariables required for 
the present analysis.  Finally, we excluded participants with extremely elevated values (in 
excess of the mean plus 3 SDs) of serum creatinine (n=102), the dietary sodium-to-
potassium ratio (n=27), and dietary calcium (n=5) or caffeine (n=4) intake.  Thus, the number 
of subjects analyzed totaled 12,725.  For analysis, self-reported ethnicity was categorized as 
non-Hispanic White, non-Hispanic Black, and Hispanic.  
Compared with the 17,066 excluded adults whose ethnicity was undetermined or who had 
no blood pressure data, the 12,725 analyzed adults were older (49.4 vs. 50.8 years), had 
lower systolic blood pressure (125.9 vs. 124.5 mm Hg) and included fewer Blacks (25.5% vs. 
21.2%), Hispanics (22.6% vs. 20.5%), and women (53.0% vs. 48.7%).  All P-values for these 
comparisons were less than 0.0001.  However, diastolic blood pressure did not differ be-
tween excluded and included adults (70.1 vs. 69.8 mm Hg; P =0.068).    
Measurements   
The questionnaires administered at home and MEC provided detailed information on each 
participant’s medical history, use of drugs, smoking and drinking habits, lifestyle, educational 
achievement, and socio-economic status.  Participants who reported using smoking materi-
als some days or every day or consuming at least one drink per week were categorized as 
smokers and drinkers, respectively.  At MEC, trained observers measured anthropometric 
characteristics and blood pressure and administered the questionnaire on dietary habits.  
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Following the guidelines of the American Heart Association, the observers measured each 
person’s blood pressure on the right arm to the nearest 2 mm Hg with a standard mercury 
sphygmomanometer by auscultation of the Korotkoff sounds after participants had rested in 
the seated position for at least 5 minutes.  Three cuff sizes were used depending on arm cir-
cumference: adult size if arm circumference was 22 to 29.9 cm (bladder width  length, 12  
22 cm); large adult size if arm circumference was 30 to 37.9 cm (15  32 cm); and adult thigh 
size if arm circumference was 38 to 47.9 cm (18  35 cm).2-5  Observers counted heart rate 
over 30 seconds.  Blood pressure was the average of up to three readings.  The number of 
blood pressure readings available for analysis was three in 11,601 participants (91.2%), two 
in 626 (4.9%) and only one in 498 (3.9%).  Hypertension was a blood pressure of at least 
140 mm Hg systolic or 90 mm Hg diastolic or use of antihypertensive drugs.  Pulse pressure 
was the difference of systolic minus diastolic blood pressure.  Mean arterial pressure was di-
astolic blood pressure plus one third of pulse pressure.  Information on diet rested on a 24-h 
dietary recall and nutrient values assigned to foods according to the US Department of Agri-
culture (USDA) Food and Nutrient Database for Diet Studies.  As described in detail else-
where,6 trained interviewers administered the 24-h dietary recalls, using an automated 
5-stage computer-aided approach.  Sodium from table salt and sodium and potassium from 
supplements and antacids were not included in the estimates of intake.   
Measurements on blood included hematocrit; serum creatinine, cholesterol, glucose, total 
calcium, and protein; serum cotinine and  -glutamyltransferase as biomarkers of smoking 
and drinking alcohol; and the blood lead concentration.  Diabetes was the use of antidiabetic 
drugs, a fasting blood glucose concentration of at least 126 mg/dL, a random blood glucose 
concentration of at least 200 mg/dL, or a self-reported diagnosis.7  Serum cotinine was 
measured by means of using an isotope dilution high performance liquid chromatography / 
atmospheric pressure chemical ionization tandem mass spectrometry method.  The detection 
limit was 0.015 ng/mL.  Blood lead was determined by the Centers for Disease Control and 
Prevention’s  National Center for Environmental Health, Division of Laboratory Sciences us-
ing inductively coupled plasma mass spectrometry.  The detection limit was 0.28 μg/dL in 
NHANES IV (2003–2004) and 0.25 μg/dL in NHANES IV (2005–2010).8  The detection of 
limit is the level at which the measurement has a 95% probability of being greater than zero.9  
Samples below the detection limit, 21 from 2003 to 2006 and 7 from 2007 to 2010 were as-
signed the limit of detection divided by the square root of 2.  
Analysis Plan  
In a first step of the analysis, we plotted mean values of systolic and diastolic blood pressure 
by deciles of the blood lead concentration for each of the six ethnicity-sex strata separately.  
We checked  the linearity of the relation between blood pressure and log blood lead by plot-
ting the cumulative Martingale residuals against log blood lead and computing the P-value of 
a Kolmogorov-type supremum test based on a sample of 1000 residual patterns.  We imple-
mented this check using the ASSESS statement in the PROC GENMOD procedure of the 
SAS software.   
Next, we searched for covariables significantly and independently associated with blood 
pressure in a stepwise regression procedure with P-values for explanatory variables to enter 
and stay in the model set at 0.15.  We considered the following explanatory variables: ethnic-
ity, sex, age, body mass index, heart rate, hematocrit, calcium, -glutamyltransferase and co-
tinine, the dietary sodium-to-potassium intake ratio, dietary intake of calcium and caffeine, 
education and the poverty index ratio, and  antihypertensive drug treatment.  The linear and 
squared terms of age as well as the design variables coding for ethnicity were offered to-
gether for entry into the regression model.  We also considered models in which the bi-
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omarkers serum -glutamyltransferase and cotinine were substituted by reported alcohol in-
take and smoking, respectively.   Finally, after having determined the standard set of covari-
ables to adjust for, we computed for each ethnicity-sex stratum the multivariable-adjusted 
associations between blood pressure and blood lead.   We tested between-group differences 
in these association by introducing the appropriate interaction terms with blood lead in the 
models.  In sensitivity analyses, we additionally adjusted for the serum creatinine concentra-
tion and the presence of diabetes mellitus or we replaced the biomarkers of alcohol intake 
and exposure to tobacco smoke, by questionnaire data on drinking and smoking habits.   
Results  
Characteristics of Participants by Ethnicity and Sex  
Whites compared with Blacks and Hispanics, were older (53.1 vs. 47.5 years) and had lower 
-glutamyltransferase (21.2 vs. 24.7 units/L), serum protein (7.06 vs. 7.33 g/dL) and a lower 
prevalence of diabetes (11.5% vs. 16.8%) and antidiabetic drug use (8.3% vs. 13.2%) with 
no differences in these measurements between Blacks and Hispanics (P≥0.077).  Blacks 
compared with Hispanics and Whites had higher systolic (126.5 vs. 123.9 mm Hg), diastolic 
(71.9 vs. 69.6 mm Hg) and mean arterial pressure (90.1 vs. 87.7 mm Hg), lower hematocrit 
(40.8% vs. 42.4%) and total cholesterol (193.4 vs. 198.5 mmol/L), and less frequently report-
ed alcohol intake (11.0% vs. 13.6%) with no differences in these variables between Hispan-
ics and Whites (P≥0.070).  Hispanics compared with Whites and Blacks had lower glucose 
(107.4 vs. 99.4 mg/dL) and included fewer smokers (18.4% vs. 23.6%) with no differences in 
these variables between Whites and Blacks (P≥0.058).  
Women compared with men (P<0.0001) had higher body mass index (29.2 vs. 28.6 
kg/m2) and heart rate (73.9 vs. 70.3 beats per minute), but lower systolic pressure (123.3 vs. 
125.5 mm Hg), diastolic pressure (68.9 vs. 71.2 mm Hg) and mean arterial pressure (87.1 vs. 
89.3 mm Hg).  Compared with men (P<0.0001), women also had lower hematocrit  (39.6 vs. 
44.4%) and lower serum levels of total cholesterol (194.6 vs. 200.5 mg/dL), creatinine (0.79 
vs.1.00 mg/dL), glucose  (99.0 vs.102.9 mg/dL), protein (7.13 vs. 7.21 g/dL), total calcium 
(9.45 vs. 9.49 mg/dL), -glutamyltransferase (19.2 vs. 26.3 units/L) and cotinine (0.25 vs. 
0.72 ng/mL).  Women compared with men (P≤0.0069), had lower dietary values of the sodi-
um-to-potassium ratio (1.35 vs. 1.39) and intake of calcium (0.67 vs. 0.82 g/day) and caffeine 
(46.7 vs. 64.2 mg/day), less frequently reported smoking (19.6 vs. 25.3%) and drinking (5.8 
vs. 20.7%), but had a higher frequency of antihypertensive drug use (30.3 vs. 27.1%), pov-
erty index ratio below threshold (19.3 vs. 16.3 %) and high-school education attainment (74.2 
vs. 72.1%).  Age (50.8 years) and pulse pressure (54.4 mm Hg) and the prevalence of hyper-
tension (38.5%), diabetes (13.7%), use of antidiabetic drugs (10.3%) and attaining a college 
graduate degree or above (20.3%) were similar among women and men (P≥0.11).  
Pulse Pressure and Mean Arterial Pressure in Relation to Blood Lead  
Unadjusted Analyses  
In unadjusted analyses of all participants, pulse pressure and mean arterial blood pressure 
as well as systolic and diastolic pressure increased (P<0.0001) with higher blood lead (Table 
S2).  The effect sizes associated with a doubling of the blood lead concentration were 4.13 
mm Hg (95% confidence interval [CI], 3.79 to 4.47) for pulse pressure and 2.04 (CI, 1.83 to 
2.26) for mean arterial pressure (Table S2).  These findings were consistent across the six 
ethnicity-sex strata (P≤0.0095).   
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Identification of Covariables   
Covariables of pulse pressure and mean arterial pressure, as selected by stepwise regres-
sion, appear in Tables S4.  Age was the most important independent covariable, explaining 
31.7% and 8.02% of the variance in pulse pressure and mean arterial pressure (Table S4).  
With Whites as reference, both Blacks and Hispanics had higher pulse pressure (Table S4).  
Blacks also had higher mean arterial pressure (Table S4).  Pulse pressure was inversely as-
sociated with heart rate, whereas the opposite was the case for mean arterial pressure.  Both 
pulse pressure and mean arterial pressure significantly (P≤0.0014) and independently in-
creased with body mass index, -glutamyltransferase as index of alcohol intake, and serum 
total calcium.  Users of antihypertensive drugs had higher blood pressure.  Mean arterial 
pressure increased with the hematocrit and the dietary sodium-to-potassium ratio.  Mean ar-
terial pressure was independently and inversely correlated with serum cotinine, whereas the 
association of cotinine with pulse pressure was positive.  College graduation was associated 
with lower pulse pressure and mean arterial pressure.  Taken together, all covariables se-
lected explained 35.6% of pulse pressure and 14.8% of mean arterial pressure.   
Multivariable-Adjusted Analyses  
Among women, the multivariable-adjusted associations between pulse pressure and mean 
arterial pressure and blood lead (Table S5) did not reach significance in any of the ethnic 
groups (P≥0.11), except for mean arterial pressure in White women, which for a twofold in-
crease in blood lead was +0.69 mm Hg higher (CI, +0.18 to +1.21; P=0.0081).  In all women 
combined, the effect sizes associated with a doubling of the blood lead concentration were 
+0.15 (CI, –0.37 to +0.67; P=0.57) for pulse pressure and +0.48 mm Hg (CI, +0.10 to +0.86; 
P=0.012) for mean arterial pressure.  Among men, mean arterial pressure was significantly 
and independently associated with the blood lead concentration in Black and White men 
(P≤0.010), whereas the corresponding association in Hispanic men was not significant 
(P=0.33).  The effect sizes for a doubling of the blood lead concentration ranged from +1.08 
mm Hg in Blacks to +0.68 mm Hg in Whites.  In all men combined, the effect size was +0.57 
mm Hg (CI, +0.24 to +0.91; P=0.0007).  The relation between pulse pressure and blood lead 
did not reach formal significance (P≥0.14) among Black and White men and in all ethnic 
groups combined, although pulse pressure was significantly associated with the blood lead 
concentration in Hispanic men, in whom the effect size was +0.98 mm Hg (CI, +0.14 to 
+1.82; P=0.023).   
Among all participants, mean arterial pressure was 0.54 mm Hg higher (CI, 0.29 to 0.79; 
P<0.0001) for each twofold increase in the blood lead concentration, whereas there was no 
significant association between pulse pressure and blood lead even when all participants 
were pooled (Table S5).  For pulse pressure, interactions of ethnicity and sex with the blood 
lead concentration were all significant (P≤0.027).  For mean arterial pressure components, all 
interaction terms of ethnicity and sex with the blood lead concentration were nonsignificant 
(P≥0.096).   
Sensitivity Analyses  
If we additionally adjusted for serum creatinine concentration and the presence of diabetes 
mellitus (Tables S6, S7 and S8) or if we replaced -glutamyltransferase and cotinine, bi-
omarkers of alcohol consumption and smoking, by questionnaire data (data not shown), our 
results did not materially change.   Our result also remained consistent with 3645 participants 
on antihypertensive drug treatment excluded (data not shown).   
Worse renal function might affect the renal excretion of blood lead and might therefore 
lead to a higher blood lead concentration.  In an unadjusted model involving all participants, 
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the simple correlation coefficient between blood lead and serum creatinine was 0.27 
(P<0.0001).  Each 1-SD (0.22 mg/dL) increment in serum creatinine was associated with a 
18.6% higher blood lead concentration (CI, 17.3 to 19.9%; P<0.0001).  With adjustments ap-
plied for ethnicity, sex, the linear and square terms of age, mean arterial pressure, body 
mass index, serum -glutamyltransferase and cotinine, diabetes, and use of antihypertensive 
drugs, this estimate was 4.73% (CI, 3.55 to 5.94%; P<0.0001).   
Discussion  
Summary of Previous NHANES IV Findings  
Two previous NHANES IV studies reported on the association of blood pressure or the risk of 
hypertension with blood lead.10,11  Both studies reported inconsistent associations across 
strata defined by ethnicity and sex.  Based on NHANES data IV (1999–2002), Muntner and 
colleagues reported that with multivariable adjustments applied persons in the highest quar-
tile of blood lead (≥2.47 μg/dL) compared with those in the lowest quartile (<1.06 μg/dL) were 
2.72 and 1.92 times more likely (P-value for trend <0.001) to have chronic kidney disease 
and peripheral arterial disease.  However, the trend of the adjusted odds ratios for hyperten-
sion with increasing category of blood lead was weak, being nonsignificant in Whites 
(P=0.61), and marginally significant in Blacks (P=0.06) and Hispanics (P=0.04).  Scinicariello 
and colleagues assessed the relation between blood pressure outcomes and blood lead 
among people with a blood lead level below 10 g/dL, using data from the NHANES IV 
(1999–2006) stratified by ethnicity and sex.11  There was a multivariable-adjusted positive 
association between systolic blood pressure and blood lead among Black women and men, 
but not in White or Hispanic participants.  Diastolic blood pressure was significantly associat-
ed with blood lead among White women and men and Black men, whereas a negative asso-
ciation was observed in Hispanic men.  Black men in the top decile of the blood lead distribu-
tion (≥3.5 g/dL) compared with Black men in the bottom decile (≤0.7 g/dL) had a signifi-
cantly increased risk of having hypertension, while no significant association was observed in 
any other of the ethnicity-sex groups.11   
Meta-analyses  
Two meta-analyses of summary statistics12,13 addressed the association between blood 
pressure12 or hypertension12,13 with lead exposure as quantified from blood12,13 or bone13 
lead.  In our own meta-analysis based on 58,518 subjects, recruited from the general popula-
tion in 19 surveys and from occupationally exposed groups in 12 studies, the association be-
tween blood pressure and low-level lead exposure was weak with effect sizes for a doubling 
of the blood lead concentration of 1 mm Hg systolic and 0.6 mm Hg diastolic.12  A more re-
cent meta-analysis conducted by Navas-Acien and colleagues found statistically significant 
associations between blood pressure and bone lead but not consistent among the different 
measures of bone lead.13  These researchers, summarized data from five cross-sectional 
studies.  All studies measured lead levels in tibia bone and three studies measured lead lev-
els also in patella.  For a 10 g/g increase in tibia lead, the cross-sectional pooled estimates 
for increases in blood pressure were 0.26 mm Hg systolic (CI, 0.02 to 0.50) and 0.02 mm Hg 
diastolic (CI, –0.15 to 0.19).  For a 10 g/g increase in patella lead, the pooled odds ratio for 
hypertension was 1.04 (CI, 0.96 to 1.12).  All studies included in Navas-Acien’s meta-
analysis also measured blood lead.  For a 5 g/dL increment in blood lead, the pooled esti-
mate for an increase in blood pressure was 1.53 mm Hg systolic (CI, –0.19 to 3.25) and 1.19 
mm Hg diastolic (CI, –0.69 to 3.08).  Navas-Acien also summarized three prospective studies, 
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but the pooled statistics did not show any association between change in blood pressure or 
incidence of hypertension with the baseline measures of lead exposure.   
Prospective studies in populations or workers  
To our knowledge, prospective studies in populations14-16 or workers17,18 did not show a 
consistent relation between change in blood pressure or incidence of hypertension and the 
baseline biomarkers of lead exposure, either the blood lead concentration14-18 or bone 
lead.14,17,18  We studied a random population sample of 728 people in 1985–1989 (partici-
pation rate, 78%) and re-examined the participants in 1991–1995 (81%).16  At baseline and 
follow-up, we measured blood pressure by conventional sphygmomanometry (average of 15 
readings in total) and at follow-up also by 24-h ambulatory monitoring.  Exposure was esti-
mated from lead and zinc protoporphyrin in blood.16  Blood lead averaged 8.7 µg/dL at base-
line and over 5.2 years of follow-up (median) dropped by 2.9 µg/dL (32% decrease).  Over 
the follow-up period no consistent associations emerged between the changes in the con-
ventionally measured blood pressure and in the biomarkers of lead exposure.  In addition, 
baseline blood lead and zinc protoporphyrin did not predict the development of hypertension 
in 47 patients; the risk ratio for doubling of the initial blood lead was 1.2 (CI, 0.7 to 2.0).  
Similarly, the 24-h blood pressure at follow-up did not show a consistent relation with the bi-
omarkers of exposure at baseline or at follow-up.   
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Table S1.   Unadjusted Associations of Systolic and Diastolic Blood Pressure with Blood Lead  
Strata  
by Ethnicity and Sex    
 Systolic Blood Pressure  
(mm Hg)   
 Diastolic Blood Pressure  
(mm Hg)   
 Effect Size  
(95% CI ) 
r2, %  P   Effect Size  
(95% CI)  
r2, %  P  
Women          
Black (n=1346)   6.40 (5.23 to 7.56)  7.93  <0.0001  0.86 (0.15 to 1.58)  0.42 0.018  
Hispanic (n=1233)   4.99 (3.75 to 6.24)  4.77  <0.0001  0.79 (0.14 to 1.45)  0.45 0.018  
White (n=3620)   6.99 (6.26 to 7.72)  8.92  <0.0001  0.08 (–0.34 to 0.51)  >0.01  0.69  
All women (n=6199)   6.50 (5.95 to 7.05)  7.91  <0.0001  0.49 (0.17 to 0.81)  0.14  0.0028  
Men          
Black (n=1346)   4.38 (3.41 to 5.34)  5.56  <0.0001  1.32 (0.59 to 2.05)  0.93  0.0004  
Hispanic (n=1374)   2.18 (1.25 to 3.12)  1.50  <0.0001  0.13 (–0.50 to 0.76)  0.01  0.69  
White (n=3806)   3.40 (2.79 to 4.00)  3.05  <0.0001  –0.22 (–0.65 to 0.22)  0.02  0.33  
All men (n=6526)   3.31 (2.86 to 3.76)  3.08  <0.0001  0.22 (–0.10 to 0.55)  0.03  0.17  
All participants (n=12,725)    4.80 (4.46 to 5.14)  5.64  <0.0001  0.67 (0.45 to 0.89)  0.28  <0.0001  
Effect sizes (95% confidence interval [CI]) express the change in blood pressure associated with a doubling of the blood lead concentration.   
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Table S2.   Unadjusted Associations of Pulse Pressure and Mean Arterial Pressure with Blood Lead  
Strata  
by Ethnicity and Sex    
 Pulse Pressure  
(mm Hg)    
 Mean Arterial Pressure  
(mm Hg)   
 Effect Size  
(95% CI ) 
r2, %  P   Effect Size  
(95% CI)  
r2, %  P  
Women          
Black (n=1346)   5.52 (4.43 to 6.61)  6.86  <0.0001  2.70 (1.98 to 3.43)  3.80  <0.0001 
Hispanic (n=1233)   4.20 (3.04 to 5.36)  3.95  <0.0001  2.19 (1.48 to 2.91)  2.87 <0.0001 
White (n=3620)   6.91 (6.17 to 7.64)  8.51  <0.0001  2.39 (1.97 to 2.81)  3.33  <0.0001 
All women (n=6199)   6.01 (5.47 to 6.55)  7.12  <0.0001  2.49 (2.17 to 2.81)  3.54  <0.0001 
Men          
Black (n=1346)   3.06 (2.14 to 3.98)  3.06  <0.0001  2.34 (1.65 to 3.04)  3.18  <0.0001 
Hispanic (n=1374)   2.05 (1.14 to 2.96)  1.41  <0.0001  0.81 (0.20 to 1.43)  0.49  0.0095  
White (n=3806)   3.61 (2.99 to 4.23)  3.31  <0.0001  0.99 (0.58 to 1.39) 0.59  <0.0001 
All men (n=6526)   3.09 (2.64 to 3.53)  2.72  <0.0001  1.25 (0.95 to 1.56)  0.99  <0.0001 
All participants (n=12,725)    4.13 (3.79 to 4.47)  4.35  <0.0001  2.04 (1.83 to 2.26)  2.69  <0.0001 
Effect sizes (95% confidence interval [CI]) express the change in blood pressure associated with a doubling of the blood lead concentration.   
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Table S3.   Unadjusted Associations between Hypertension and Blood 
Lead  
Strata  
by Ethnicity and Sex    
 Odds Ratio  
(95% CI )  
P  
Women     
Black (n=1346)   2.14 (1.87 to 2.46)  <0.0001  
Hispanic (n=1233)   1.51 (1.32 to 1.73)  <0.0001  
White (n=3620)   2.17 (1.99 to 2.37)  <0.0001  
All women (n=6199)   2.02 (1.89 to 2.15)  <0.0001  
Men     
Black (n=1346)   1.63 (1.44 to 1.85)  <0.0001  
Hispanic (n=1374)   1.10 (0.98 to 1.25)  0.12  
White (n=3806)   1.53 (1.41 to 1.65)  <0.0001  
All men (n=6526)   1.41 (1.33 to 1.49)  <0.0001 
All participants (n=12,725)   1.58 (1.52 to 1.65)  <0.0001  
Effect sizes are odds ratios (95% confidence interval [CI]) associated with a doubling of the 
blood lead concentration.  
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Table S4.   Correlates of Pulse Pressure and Mean Arterial Pressure  
Covariables   
 Pulse Pressure 
(mm Hg)  
 Mean Arterial Pressure 
(mm Hg)   
 Effect size  
(95% CI ) 
r2  
(%) 
P   Effect size  
(95% CI)  
r2  
(%) 
P  
Black vs. white (1,0)    1.86 (1.17 to 2.55)  
0.90  
<0.0001   2.75 (2.25 to 3.36)  
1.44  
<0.0001  
Hispanic vs. white (1,0)   3.30 (2.60 to 4.00)  <0.0001   –0.15 (–0.66 to 0.36)  0.56  
Female sex (1,0)    …  …  …   –0.35 (–0.81 to 0.12)  0.01  0.15  
Age (+18.0 y)   –21.8 (–23.4 to –20.2)  
31.7  
<0.0001   14.3 (13.1 to 15.5)  
8.02  
<0.0001  
Age2 (+1875 y2)   30.5 (28.9 to 32.2)  <0.0001   –12.3 (–13.5 to –11.1)  <0.0001  
Body mass index (+6.5 kg/m2)    0.83 (0.55 to 1.11)  0.14  <0.0001   0.73 (0.52 to 0.93)  0.99  <0.0001  
Heart rate (+12.2 beats/minute)   –1.82 (–2.09 to –1.56)  0.57  <0.0001   0.72 (0.52 to 0.91)  0.35  <0.0001  
-glutamyltransferase ( 2)    1.22 (0.92 to 1.52)  0.31  <0.0001   0.96 (0.74 to 1.18)  0.67  <0.0001  
Cotinine ( 2)   0.16 (0.10 to 0.21)  0.14  <0.0001   –0.13 (–0.16 to –0.09)  0.20  <0.0001  
Hematocrit (+4.3%)   –1.23 (–1.51 to –0.95)  0.25  <0.0001   1.89 (1.65 to 2.13)  2.50  <0.0001  
College graduate (1, 0)    –2.19 (–2.88 to –1.51)  0.39  <0.0001   –1.24 (–1.74 to –0.74)  0.16  <0.0001  
Antihypertensive drugs (1,0)   3.87 (3.20 to 4.54)  1.12  <0.0001   1.75 (1.27 to 2.24)  0.37  <0.0001  
Dietary sodium-to-potassium ratio (+0.60)   …  …  …   0.34 (0.15 to 0.54) 0.07  0.0006  
Serum total calcium (+0.37 mg/dL)   0.62 (0.35 to 0.89)  0.10  <0.0001   0.32 (0.12 to 0.52)  0.06  0.0014  
Total explained variance (R2)    35.6     14.8   
Effect sizes (95% confidence interval [CI]) express the multivariable-adjusted change in blood pressure associated with the explanatory variables, as cat-
egory, on a linear scale (+ 1-SD), or on a logarithmic scale (doubling).  The explanatory variables were selected by a stepwise regression procedure with 
the P-values for variables to enter and stay in the models set at 0.15.  The linear and squared terms of age as well as the design variables coding for eth-
nicity were offered together for entry into the model.  An ellipsis indicates that a variable did not enter the model.  Variables considered that did not enter 
in any model were dietary intake of calcium and caffeine, and the poverty index ratio.  R2 and r2 indicate the variance explained in percent by the whole 
model or by single or sets of variables.   
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Table S5.   Multivariable Adjusted Association of Pulse Pressure and Mean Arterial Pressure with Blood Lead  
Strata  
by Ethnicity and Sex    
 Pulse Pressure  
(mm Hg)   
 Mean Arterial Pressure  
(mm Hg)   
 Effect Size  
(95% CI ) 
r2, %  P   Effect Size  
(95% CI)  
r2, %  P  
Women          
Black (n=1346)   0.64 (–0.56 to 1.84)  0.05  0.30   0.73 (–0.16 to 1.62)  0.16  0.11  
Hispanic (n=1233)   0.69 (–0.29 to 1.67)  0.08  0.17   0.10 (–0.62 to 0.82)  >0.00  0.79  
White (n=3620)   –0.11 (–0.84 to 0.61)  >0.00  0.76   0.69 (0.18 to 1.21)  0.17  0.0081  
All women (n=6199)   0.15 (–0.37 to 0.67)  >0.00  0.57   0.48 (0.10 to 0.86)  0.09  0.012  
Men          
Black (n=1346)   0.81 (–0.27 to 1.88)  0.13  0.14   1.08 (0.26 to 1.90)  0.42  0.010  
Hispanic (n=1374)   0.98 (0.14 to 1.82)  0.28  0.023   0.30 (–0.30 to 0.89)  0.06  0.33  
White (n=3806)   –0.06 (–0.68 to 0.57)  >0.00  0.86   0.68 (0.23 to 1.14)  0.20  0.0035  
All men (n=6526)   0.32 (–0.13 to 0.77)  0.02  0.16   0.57 (0.24 to 0.91)  0.15  0.0007  
All participants (n=12,725)    0.33 (–0.02 to 0.67)  0.02  0.063   0.54 (0.29 to 0.79)  0.12  <0.0001  
Effect sizes (95% confidence interval [CI]) express the multivariable-adjusted change in blood pressure associated with a doubling of the blood lead 
concentration.  Estimates were adjusted for ethnicity and/or sex (as appropriate), the linear and squared terms of age, body mass index, heart rate, 
hematocrit, serum total calcium, -glutamyltransferase and cotinine, the dietary sodium-to-potassium intake ratio, college education, and antihyperten-
sive drug treatment.   
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Table S6.   Adjusted Associations of Systolic and Diastolic Pressure with Blood Lead Considering Additional  
Covariables  
Strata  
by Ethnicity and Sex   
 Systolic Blood Pressure  
(mm Hg)   
 Diastolic Blood Pressure 
(mm Hg)   
 Effect Size  
(95% CI ) 
r2, %  P   Effect Size  
(95% CI)  
r2, %  P  
Women          
Black (n=1346)   1.31 (–0.07 to 2.69)  0.19  0.062   0.47 (–0.39 to 1.33)  0.07  0.29  
Hispanic (n=1233)   0.48 (–0.65 to 1.62)  0.03  0.41   –0.28 (–0.97 to 0.40)  0.05  0.41  
White (n=3620)   0.77 (–0.02 to 1.57)  0.06  0.057   0.66 (0.16 to 1.17)  0.15  0.010  
All women (n=6199)   0.69 (0.10 to 1.28)  0.06  0.021   0.33 (–0.03 to 0.70)  0.04  0.075  
Men          
Black (n=1346)   1.60 (0.44 to 2.77)  0.45  0.0071   0.69 (–0.17 to 1.54)  0.15  0.11  
Hispanic (n=1374)   0.94 (0.03 to 1.85)  0.23  0.042   –0.23 (–0.85 to 0.39)  0.03  0.46  
White (n=3806)   0.59 (–0.10 to 1.27)  0.06  0.092   0.48 (0.01 to 0.95)  0.08  0.047  
All men (n=6526)   0.75 (0.25 to 1.24)  0.11  0.0029   0.27 (–0.07 to 0.61)  0.03  0.12  
All participants (n=12,725)    0.78 (0.40 to 1.16)  0.09  <0.0001   0.28 (0.03 to 0.53)  0.03  0.0029  
Effect sizes (95% confidence interval [CI]) express the multivariable-adjusted change in blood pressure associated with a doubling of the blood lead 
concentration.  Estimates were adjusted for ethnicity and/or sex (as appropriate), the linear and squared terms of age, body mass index, heart rate, 
hematocrit, serum creatinine, total calcium, -glutamyltransferase and cotinine, the dietary sodium-to-potassium intake ratio, college education, diabe-
tes mellitus, and  antihypertensive drug treatment.   
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Table S7.   Adjusted Associations of Pulse Pressure and Mean Arterial Pressure with Blood Lead Considering  
Additional Covariables    
Strata  
by Ethnicity and Sex    
 Pulse Pressure  
(mm Hg)   
 Mean Arterial Pressure  
(mm Hg)   
 Effect Size  
(95% CI ) 
r2, %  P   Effect Size  
(95% CI)  
r2, %  P  
Women          
Black (n=1346)   0.82 (–0.39 to 2.03)  0.09  0.19   0.74 (–0.15 to 1.63)  0.17  0.10  
Hispanic (n=1233)   0.77 (–0.22 to 1.75)  0.10  0.13   –0.03 (–0.75 to 0.70)  >0.00  0.94  
White (n=3620)   0.12 (–0.61 to 0.84)  <0.00  0.75   0.70 (0.19 to 1.22)  0.17  0.0078  
All women (n=6199)   0.36 (–0.17 to 0.88)  0.02  0.18   0.45 (0.073 to 0.83)  0.07  0.019  
Men          
Black (n=1346)   0.92 (–0.16 to 2.01)  0.17  0.094   1.00 (0.17 to 1.82)  0.35  0.018  
Hispanic (n=1374)   1.17 (0.32 to 2.02)  0.39  0.0070   0.16 (–0.45 to 0.77)  >0.00  0.60  
White (n=3806)   0.11 (–0.52 to 0.74)  <0.00  0.74   0.51 (0.05 to 0.98)  0.11  0.030  
All men (n=6526)   0.48 (0.02 to 0.93)  0.05  0.040   0.43 (0.09 to 0.77)  0.08  0.012  
All participants (n=12,725)    0.50 (0.15 to 0.85)  0.04  0.0046   0.44 (0.19 to 0.70)  0.08  0.0005  
Effect sizes (95% confidence interval [CI]) express the multivariable-adjusted change in blood pressure associated with a doubling of the blood lead 
concentration.  Estimates were adjusted for ethnicity and/or sex (as appropriate), the linear and squared terms of age, body mass index, heart rate, 
hematocrit, serum creatinine, total calcium, -glutamyltransferase and cotinine, the dietary sodium-to-potassium intake ratio, college education, diabe-
tes mellitus, and  antihypertensive drug treatment.   
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Table S8.   Adjusted Association between Hypertension and Blood 
Lead Considering Additional Covariables   
Strata  
by Ethnicity and Sex    
 Odds Ratio  
(95% CI )  
P  
Women     
Black (n=1346)   0.82 (0.67 to 1.01)  0.063  
Hispanic (n=1233)   0.91 (0. 75 to 1.11)  0.36  
White (n=3620)   1.09 (0.96 to 1.24)  0.20  
All women (n=6199)   0.98 (0.89 to 1.07)  0.64  
Men     
Black (n=1346)   0.99 (0.82 to 1.19)  0.93  
Hispanic (n=1374)   0.90 (0.75 to 1.06)  0.21  
White (n=3806)   1.00 (0.90 to 1.12)  0.94  
All men (n=6526)   0.97 (0.89 to 1.05)  0.39  
All participants (n=12,725)   0.98 (0.92 to 1.04)  0.51  
Effect sizes (95% confidence interval [CI]) express the multivariable-adjusted risk of having  
hypertension associated with a doubling of the blood lead concentration.  Odds ratios were 
adjusted for ethnicity and/or sex (as appropriate), the linear and squared terms of age, body 
mass index, heart rate, hematocrit, serum creatinine, total calcium, -glutamyltransferase and 
cotinine, college education, the dietary sodium-to-potassium intake ratio, and diabetes melli-
tus.  
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Figure S1.  
Distributions of the log blood lead concentration by ethnicity (Blacks, A and  D; Hispanics, B and E; 
and Whites, C and F) and sex (women, A, B, and C; men D, E, and F).  S and K are the coefficients 
of skewness and kurtosis, respectively.  The dotted line is the fitted normal distribution; the full line 
is the fitted Kernel distribution; and the P-value calculated by Kolmogorov-Smirnov test are for de-
parture from normality.  
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Figure S2.   
Unadjusted associations between diastolic blood pressure and blood lead by 6 ethnicity-
sex strata.  The regression line with 95% confidence interval was computed using the indi-
vidual subjects in each stratum.  The dots plotted over the regression line represent the 
means of diastolic blood pressure and lead in each decile of the ethnicity- and sex-specific 
distributions.  Vertical bars denote the standard error of diastolic blood pressure.  The Fig-
ure illustrates the adequacy of the linear model.    
